-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
PharmaCyte Biotech, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2012 to Q1 2024.
- PharmaCyte Biotech, Inc. Deferred Tax Assets, Gross for the quarter ending April 30, 2024 was $15.2M, a 6.38% decline year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)